Physician profile
William E Mcrae
NPI 1851421051
$637.92
in general payments reported to CMS, 2019-2025
17 companies · $42.60 in 2025
The $42.60 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $418 · 2020: $60.70 · 2021: $34.99 · 2022: $12.35 · 2023: $33.12 · 2024: $36.52 · 2025: $42.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $112.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $162.09 | 2019-2020 | |
| Stimwave Technologies Incorporated | $134.43 | 2019 | |
| Scilex Pharmaceuticals INC. | $64.73 | 2019-2024 | Ztlido |
| Vertex Pharmaceuticals Incorporated | $60.46 | 2024-2025 | |
| Boston Scientific Corporation | $36.65 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.10 | 2020-2021 | |
| Si-Bone, INC. | $20.13 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.06 | 2019 | |
| Collegium Pharmaceutical, INC. | $14.98 | 2019 | |
| Daiichi Sankyo INC. | $12.94 | 2019 | |
| B. Braun Medical INC. | $12.73 | 2019 | |
| Pfizer INC. | $12.72 | 2019 | |
| Almatica Pharma LLC | $12.35 | 2022 | |
| Lilly USA, LLC | $12.33 | 2019 | |
| Amgen INC. | $12.02 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $11.75 | 2019 | |
| Abbott Laboratories | $11.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Mcrae listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.